Article (Scientific journals)
Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
van Winkel, Ruud; De Hert, Marc; Wampers, Martien et al.
2008In Journal of Clinical Psychiatry, 69 (3), p. 472-9
Peer Reviewed verified by ORBi
 

Files


Full Text
Major changes in glucose metabolism jcp.pdf
Publisher postprint (230.04 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Adult; Aged; Antipsychotic Agents/adverse effects; Benzodiazepines/adverse effects/therapeutic use; Blood Glucose; Body Mass Index; Clozapine/adverse effects/therapeutic use; Diabetes Mellitus, Type 2/chemically induced/epidemiology/metabolism; Dibenzothiazepines/adverse effects/therapeutic use; Fasting; Female; Food Habits; Glucose/metabolism; Glucose Tolerance Test; Humans; Incidence; Insulin/blood; Male; Middle Aged; Piperazines/adverse effects/therapeutic use; Prevalence; Psychotic Disorders/drug therapy/epidemiology; Quinolones/adverse effects/therapeutic use; Risk Factors; Schizophrenia/drug therapy/epidemiology; Time Factors
Abstract :
[en] OBJECTIVE: To investigate 3-month changes in glucose metabolism in a naturalistic sample of patients with schizophrenia newly started on or switched to specific atypical antipsychotic medication therapy. METHOD: One hundred eighty-three patients were evaluated before initiation and 3 months after with a 75-g glucose load oral glucose tolerance test (OGTT). Data were collected between November 2003 and January 2007. RESULTS: Eight patients (4.4%) developed new-onset diabetes within 3 months. Initiation of clozapine resulted in a significantly higher risk for new-onset glucose abnormalities than initiation of aripiprazole (odds ratio = 67.29, 95% CI = 5.23 to 866.49). Significant drug x time interactions were found for all OGTT glucose assessments (fasting: F = 6.79, df = 5,177; p < .0001; 30 minutes: F = 3.89, df = 5,177; p = .0023; 60 minutes: F = 5.03, df = 5,177; p = .0002; 120 minutes: F = 3.78, df = 5,177; p = .0028), with the evolution of plasma glucose levels being significantly worse in patients initiated on clozapine therapy (fasting, 30 minutes, and 60 minutes), olanzapine therapy (fasting, 60 minutes, and 120 minutes), and quetiapine therapy (fasting and 60 minutes) than in patients initiated on aripiprazole therapy (p < .05). Clozapine was also significantly more deleterious than risperidone and amisulpride for fasting plasma glucose level changes (p < .05). Type of initiation (start or switch) did not affect any of the metabolic parameters. CONCLUSIONS: The incidence of new-onset glucose abnormalities, including diabetes, in the first 3 months after newly starting or switching atypical antipsychotic medication is high and may be markedly influenced by type of prescribed antipsychotic. The importance of accurately screening for new-onset glucose abnormalities after initiation of an atypical antipsychotic is emphasized.
Disciplines :
Psychiatry
Endocrinology, metabolism & nutrition
Author, co-author :
van Winkel, Ruud
De Hert, Marc
Wampers, Martien
Van Eyck, Dominique
Hanssens, Linda
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Peuskens, Joseph
Language :
English
Title :
Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
Publication date :
2008
Journal title :
Journal of Clinical Psychiatry
ISSN :
0160-6689
eISSN :
1555-2101
Publisher :
Physicians Postgraduate Press, Memphis, United States - Tennessee
Volume :
69
Issue :
3
Pages :
472-9
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 17 December 2008

Statistics


Number of views
112 (4 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
95
Scopus citations®
without self-citations
76
OpenCitations
 
70

Bibliography


Similar publications



Contact ORBi